Please assess the completion status of the following clinical trial:

Trial Title: GlycoCholic Acid Treatment for Patients With Inborn Errors in Bile Acid Synthesis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Confirmation of a diagnosis of an inborn error of bile acid synthesis/conjugation based upon urine analysis by FAB-MS.~2. Any age~3. Participant must be willing and able to comply with study assessments and procedures.~4. The participant and/or parent/legal guardian must have signed the written informed consent document prior to study start.~Exclusion Criteria~1. No confirmed diagnosis of inborn error of bile acid synthesis/conjugation based upon urine analysis by FAB-MS.

- Gender: ALL
- Minimum Age: 1 Week
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- GlycoCholic Acid, Study Drug (Type: EXPERIMENTAL): An open label, single arm, non-randomized, non-comparative, treatment study of Glycocholic Acid in the treatment of defects of bile acid metabolism.

Based on this trial design, predict the completion outcome and termination type (if applicable).